申请人:Alzheon, Inc.
公开号:US20220087967A1
公开(公告)日:2022-03-24
Provided herein is the use of a compound of Formula (I) or a pharmaceutically acceptable salt thereof, for treating a disease characterized by amyloid and amyloid-like aggregates, e.g., Alzheimer's disease.